Co-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) announced its participation in the 89th Annual American Mosquito Control Association (AMCA) conference from February 28 to March 3, 2023, in Reno, Nevada. The event is a key networking opportunity for professionals in mosquito control, where Co-Diagnostics will showcase its vector control PCR products. After a year of growth in laboratory installations and reagent purchases, the Company aims to enhance its market presence. Attendees can visit Booth #107 to learn more about Co-Diagnostics' offerings, including its Vector Smart™ tests. For more details about the conference, visit the AMCA website.

News Market Reaction – CODX

+0.70%

+0.70% Session move

In the trading session that priced this news, CODX gained 0.70%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Feb. 28, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming 89^th annual American Mosquito Control Association (AMCA) conference on February 28-March 3 in Reno, Nevada.

The AMCA Annual Meeting is listed as the premier education and networking event for researchers, educators, vector control professionals, industry representatives, and students in mosquito control. Co-Dx believes the event will provide opportunities for Company representatives to introduce Co-Diagnostics vector control PCR products to a wide array of professionals in the field, following a year where the Company saw growth in terms of both new laboratory installations and reagent purchases from existing customers.

To learn more about the conference, including registration details, please visit https://www.eventscribe.net/2023/AMCA. Attendees interested in learning more about the Company and its products, including its suite of Vector Smart™ tests and other equipment, are invited to visit Booth #107.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-89th-annual-amca-conference-in-reno-nv-on-feb-28-march-3-301758287.html

SOURCE Co-Diagnostics

FAQ

What event is Co-Diagnostics hosting a booth at in February 2023?

Co-Diagnostics is hosting a booth at the 89th Annual American Mosquito Control Association conference from February 28 to March 3, 2023.

Where is the 89th AMCA conference taking place?

The 89th AMCA conference is taking place in Reno, Nevada.

What products will Co-Diagnostics showcase at the AMCA conference?

Co-Diagnostics will showcase its vector control PCR products and its Vector Smart™ tests at the AMCA conference.

What growth did Co-Diagnostics experience before the AMCA conference?

Co-Diagnostics experienced growth in new laboratory installations and reagent purchases from existing customers.

How can I get more information about the AMCA conference?

More information about the AMCA conference can be found on their official website: https://www.eventscribe.net/2023/AMCA.

What is the stock symbol for Co-Diagnostics?

The stock symbol for Co-Diagnostics is CODX.